Previous Posts
- Clot-Blocking Drug for Stroke Patients Advised Can...
- FDA Approves Generic Version of Plan B Emergency C...
- 600 Neighborhoods Have Elevated Cancer Risks
- Faulty Insurance Database Overcharged Patients for...
- Deaths Associated with Gardasil Increased in 2008
- Physicians Often Fail to Inform Patients of Abnorm...
- Does Fish Oil, Vitamin D Lower Risk of Cancer or H...
- President Obama Signs Bill Giving the FDA the Powe...
- NYC Hospital Suspected in Death Cover- Up
- Promising New Liver Cancer Treatment in Clinical T...
Click Here to View
Our Other Site
Monday, June 29, 2009
Piroxicam Label in Canada to be Revised
On June 25, 2009, Health
Piroxicam is a prescription drug in the family known as non-selective non-steroidal anti-inflammatory drugs (NSAIDs), and is used to relieve pain and inflammation.
The risks associated with its use as a treatment for acute, short-term pain do not outweigh the benefits relative to alternative treatment options. Piroxicam should still be used for chronic pain and inflammation in patients suffering from certain types of chronic arthritis.
The product’s labeling will be updated to reflect the new restrictions. Health
The FDA made a similar announcement regarding all NSAIDs in May 2009.
Please report any adverse reactions associated with Piroxicam to the FDA.
The FDA can be contacted via:
Online at www.fda.gov/medwatch/report.htm
Phone at 1-800-FDA-1088
Fax at 1-800-FDA-0178, using the MedWatch Form 3500
(available at www.fda.gov/medwatch/ getforms.htm)
Mail, using the postage-paid MedWatch Form 3500 (see above), to MedWatch, 5600
Fishers Lane,
For more information please see: http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm150314.htm
http://www.hc-sc.gc.ca/ahc-asc/media/advisories-avis/_2009/2009_102-eng.php
Labels: FDA, inflammation, NSAID, pain, Piroxicam
posted by
Jessica
at
8:21 AM
<< Home